Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

To see complete record on, please visit this link

Id: NCT00252122

Organisation Name: Children's Hospital of Philadelphia

Overal Status: Terminated

Start Date: June 2004

Last Update: March 13, 2009

Lead Sponsor: Children's Hospital of Philadelphia

Brief Summary: The purpose of this pilot study is to provide a preliminary assessment of the feasibility and efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease (who are admitted to the hospital with severe, acute pain crisis, and who have been resistant to intravenous narcotics).

  • Sickle Cell Disease

Total execution time in seconds: 0.28688383102417